Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3) Meeting Abstract

  

Authors:	Kwiatkowski, D. J.; Rusch, V. W.; Chaft, J. E.; Johnson, B. E.; Nicholas, A.; Wistuba, I. I.; Merritt, R.; Lee, J. M.; Bunn, P. A.; Tang, Y.; Phan, S. C.; Waqar, S. N.; Patterson, A.; Haura, E. B.; Toloza, E. M.; Reckamp, K. L.; Raz, D.; Schulze, K.; Johnson, A.; Carbone, D. P.
Abstract Title:	Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	457s
Language:	English
ACCESSION:	WOS:000487345806381
PROVIDER:	wos
DOI:	10.1200/JCO.2019.37.15_suppl.8503
Notes:	Meeting Abstract: 8503 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156333